Trial Profile
Phase I/II Study of Sagopilone in combination with carboplatin and bevacizumab in the first-line treatment of patients with stage IIIB/IV, non-squamous NSCLC.
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 28 May 2012
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Carboplatin (Primary) ; Sagopilone (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 29 Jul 2011 New trial record